Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
HANSOH PHARMA Hyped Up 7% as 2025 NP Surges 27%; BOCI Lifts TP to HKD43.5
Recommend 1 Positive 2 Negative 0 |
||||
|
||||
|
HANSOH PHARMA (03692.HK) opened flat today and once peaked at HKD35.94. It last traded at HKD35.5, up 7.32%, with a volume of 12.3003 million shares, involving HKD431 million. The company's turnover grew by 22.6% YoY to RMB15.028 billion in 2025, while net profit rose by 27.1% YoY to RMB5.555 billion, with EPS at RMB0.93. BOCI said in its research report that HANSOH PHARMA has successfully transformed itself into an innovation-oriented pharma company, as evidenced by its strong results for 2025. The broker has reiterated a Buy rating on the drug maker and raised its target price from HKD41.3 to HKD43.5. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
